Submission for OMB Review; Comment Request; Solar Cell: A Mobile UV Manager for Smart Phones Phase II (NCI), 22331-22332 [2012-8930]
Download as PDF
Federal Register / Vol. 77, No. 72 / Friday, April 13, 2012 / Notices
site(s) to which the Corps member is
assigned.
pmangrum on DSK3VPTVN1PROD with NOTICES
Evaluation and Selection Process
In order for a site to be eligible for
placement of NHSC personnel, it must
be approved by the NHSC following the
site’s submission of a Site Application.
The processing of Site Applications
from solo or group practices may
involve additional screening, including
a site visit by NHSC representatives.
The Site Application approval is good
for a period of 3 years from the date of
approval.
In approving applications for the
assignment of Corps members, the
Secretary shall give priority to any such
application that is made regarding the
provision of primary health services to
a HPSA with the greatest shortage. For
the program year July 1, 2012, through
June 30, 2013, HPSAs of greatest
shortage for determination of priority for
assignment of NHSC scholarshipobligated Corps personnel will be
defined as follows: (1) Primary medical
care HPSAs with scores of 16 and above
are authorized for the assignment of
NHSC scholarship recipients who are
primary care physicians, family nurse
practitioners (NPs), physician assistants
(PAs) or CNMs; (2) mental health
HPSAs with scores of 16 and above are
authorized for the assignment of NHSC
scholarship recipients who are
psychiatrists or mental health nurse
practitioners; and (3) dental HPSAs with
scores of 16 and above are authorized
for the assignment of NHSC scholarship
recipients who are dentists. The NHSC
has determined that a minimum HPSA
score of 16 for all eligible clinicians will
enable it to meet its statutory obligation
to identify a number of entities eligible
for placement at least equal to, but not
greater than, twice the number of NHSC
scholars available to serve in the 2012–
2013 placement cycle.
The number of new NHSC placements
through the Scholarship Program
allowed at any one site is limited to one
(1) of the following provider types:
Physician (MD/DO), NP, PA, CNM, or
dentist. The NHSC will consider
requests for up to two (2) scholar
placements at any one site on a case-bycase basis. Factors that are taken into
consideration include community need,
as measured by demand for services,
patient outcomes and other similar
factors, and how the additional scholar
will impact retention of other clinicians.
Sites wishing to request an additional
scholar must complete an Additional
Scholar Request form available at https://
nhsc.hrsa.gov/scholarship/pdf/
additionalscholarrequestform.pdf.
VerDate Mar<15>2010
14:16 Apr 12, 2012
Jkt 226001
Sites that do not meet the authorized
HPSA score threshold indicated above
may post job openings, however,
scholars seeking placement between
July 1, 2012 and June 30, 2013 will be
advised that they can only compete for
open positions at sites that meet the
threshold placement HPSA score of 16.
While not eligible for scholar
placements in 2012–2013, vacancies in
HPSAs scoring less than 16 will be used
by the NHSC in evaluating the HPSA
threshold score for the next scholarship
placement cycle.
Application Requests, Dates and
Address
The list of HPSAs and entities that are
eligible to receive priority for the
placement of Corps personnel may be
updated periodically. Entities that no
longer meet eligibility criteria, including
those sites whose 3-year approval as an
NHSC service site has lapsed or whose
HPSA designation has been withdrawn
or proposed for withdrawal, will be
removed from the priority listing. New
entities interested in being added to the
high priority list must submit a Site
Application to the National Health
Service Corps by visiting https://
nhsc.hrsa.gov/communities/apply.htm
to apply online. A searchable database
of HPSAs and their scores, by State and
county, is posted at https://
hpsafind.hrsa.gov/.
Additional Information
Entities wishing to provide additional
data and information in support of their
inclusion on the proposed list of HPSAs
and entities that would receive priority
in assignment of scholarship-obligated
Corps members, must do so in writing
no later than May 14, 2012. This
information should be submitted to:
Sonya Bayone, Chief, Site Branch,
Division of the National Health Service
Corps, Bureau of Clinician Recruitment
and Service, 5600 Fishers Lane, Room
8–37, Rockville, MD 20857. This
information will be considered in
preparing the final list of HPSAs and
entities that are receiving priority for the
assignment of scholarship-obligated
Corps personnel.
The program is not subject to the
provisions of Executive Order 12372,
Intergovernmental Review of Federal
Programs (as implemented through 45
CFR Part 100).
Dated: April 9, 2012.
Mary K. Wakefield,
Administrator.
[FR Doc. 2012–8928 Filed 4–12–12; 8:45 am]
BILLING CODE 4165–15–P
PO 00000
Frm 00051
Fmt 4703
Sfmt 4703
22331
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Submission for OMB Review;
Comment Request; Solar Cell: A
Mobile UV Manager for Smart Phones
Phase II (NCI)
Summary: Under the provisions of
Section 3507(a)(1)(D) of the Paperwork
Reduction Act of 1995, the National
Cancer Institute (NCI), the National
Institutes of Health (NIH), has submitted
to the Office of Management and Budget
(OMB) a request to review and approve
the information collection listed below.
This proposed information collection
was previously published in the Federal
Register on January 27, 2012 (77 FR
4334) and allowed 60-days for public
comment. No public comments were
received. The purpose of this notice is
to allow an additional 30 days for public
comment. The National Institutes of
Health may not conduct or sponsor, and
the respondent is not required to
respond to, an information collection
that has been extended, revised, or
implemented on or after October 1,
1995, unless it displays a currently valid
OMB control number.
Proposed Collection: Title: Solar Cell:
A Mobile UV Manager for Smart Phones
Phase II (NCI). Type of Information
Collection Request: New. Need and Use
of Information Collection: The overall
goal of the study is to design a smart
phone application, Solar Cell, which
uses smart phone technology to aid
users in protecting their skin from
damaging ultraviolet radiation (UV) in
sunlight, a primary cause of skin cancer.
The purpose of this part of the study is
to produce, deploy, and evaluate the
effectiveness of a state-of-the-art
software application for smart phones
(i.e., mobile application), ‘‘Solar Cell.’’
This software application supports
decision-making related to sun
protection and exposure by Americans
to reduce the risk of developing skin
cancer attributable to chronic and severe
UV exposure and developing other
cancers attributable to vitamin D
deficiency. The Solar Cell mobile smart
phone application combines personal
and behavior data with geo-spatial data
(i.e., UV Index forecast, time, and
location) and delivers actionable sun
protection advice to reduce risk of skin
cancer. Frequency of Response: Once.
Affected Public: Individuals. Type of
Respondents: Adults (18 and over) from
the U.S. population who own Android
smart phones. The annual reporting
burden is estimated at 308 hours (see
Table below). There are no Capital
E:\FR\FM\13APN1.SGM
13APN1
22332
Federal Register / Vol. 77, No. 72 / Friday, April 13, 2012 / Notices
Costs, Operating Costs, and/or
Maintenance Costs to report.
A.12–1—ESTIMATES OF ANNUAL BURDEN HOURS
Number of
respondents
Frequency of
response
Average time
per response
(min/hour)
Annual
burden hours
Instrument
Adults ................................................
Screener (Appendix G) ....................
Pre-test (Appendix A) .......................
Post-test (Appendix B) .....................
1,875
245
245
1
1
1
2/60
20/60
40/60
63
82
163
Totals .........................................
pmangrum on DSK3VPTVN1PROD with NOTICES
Type of respondents
...........................................................
........................
........................
........................
308
Request for Comments: Written
comments and/or suggestions from the
public and affected agencies should
address one or more of the following
points: (1) Evaluate whether the
proposed collection of information is
necessary for the proper performance of
the function of the agency, including
whether the information will have
practical utility; (2) Evaluate the
accuracy of the agency’s estimate of the
burden of the proposed collection of
information, including the validity of
the methodology and assumptions used;
(3) Enhance the quality, utility, and
clarity of the information to be
collected; and (4) Minimize the burden
of the collection of information on those
who are to respond, including the use
of appropriate automated, electronic,
mechanical, or other technological
collection techniques or other forms of
information technology.
Direct Comments to OMB: Written
comments and/or suggestions regarding
the item(s) contained in this notice,
especially regarding the estimated
public burden and associated response
time, should be directed to the
Attention: NIH Desk Officer, Office of
Management and Budget, at
OIRA_submission@omb.eop.gov or by
fax to 202–395–6974. To request more
information on the proposed project or
to obtain a copy of the data collection
plans and instruments, contact Patricia
Weber, DrPH, Program Director, NCI/
NIH, SBIR Development Center, 6116
Executive Blvd., Suite 402, Rockville,
MD 20852 or call non-toll-free number
301–594–8106 or email your request,
including your address to:
weberpa@mail.nih.gov.
Comments Due Date: Comments
regarding this information collection are
best assured of having their full effect if
received within 30 days of the date of
this publication.
VerDate Mar<15>2010
14:16 Apr 12, 2012
Jkt 226001
Dated: April 9, 2012.
Vivian Horovitch-Kelley,
NCI Project Clearance Liaison, National
Institutes of Health.
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)
[FR Doc. 2012–8930 Filed 4–12–12; 8:45 am]
Dated: April 6, 2012.
Anna P. Snouffer,
Deputy Director, Office of Federal Advisory
Committee Policy.
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
[FR Doc. 2012–8919 Filed 4–12–12; 8:45 am]
BILLING CODE 4140–01–P
National Institutes of Health
Center for Scientific Review; Notice of
Meeting
Pursuant to section 10(a) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of a meeting of the Center
for Scientific Review Advisory Council.
The meeting will be open to the
public with attendance limited to space
available. Individuals who plan to
attend and need special assistance, such
as sign language interpretation or other
reasonable accommodations, should
notify the Contact Person listed below
in advance of the meeting.
Name of Committee: Center for Scientific
Review Advisory Council.
Date: May 14, 2012.
Time: 8 a.m. to 4:30 p.m.
Agenda: Provide advice to the Acting
Director, Center for Scientific Review (CSR),
on matters related to planning, execution,
conduct, support, review, evaluation, and
receipt and referral of grant applications at
CSR.
Place: Health and Human Services
Building, 5635 Fishers Lane, Rockville, MD
20852.
Contact Person: Donald L Schneider, Ph.D.,
Senior Advisor to the Director, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3030,
MSC 7776, Bethesda, MD 20892, (301) 435–
1111, schneidd@csr.nih.gov.
Any interested person may file written
comments with the committee by forwarding
the statement to the Contact Person listed on
this notice. The statement should include the
name, address, telephone number and when
applicable, the business or professional
affiliation of the interested person.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
PO 00000
Frm 00052
Fmt 4703
Sfmt 4703
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Human Genome Research
Institute; Notice of Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Human
Genome Research Institute Special Emphasis
Panel, H3Africa Biorepository
Teleconference SEP.
Date: April 18, 2012.
Time: 12 p.m. to 1:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Human Genome Research
Institute, 5635 Fishers Lane, 4076, Rockville,
MD 20852, (Telephone Conference Call).
Contact Person: Rudy O. Pozzatti, Ph.D.,
Scientific Review Officer, Scientific Review
Branch, National Human Genome Research
Institute, 5635 Fishers Lane, Suite 4076, MSC
9306, Rockville, MD 20852, (301) 402–0838,
pozzattr@mail.nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
E:\FR\FM\13APN1.SGM
13APN1
Agencies
[Federal Register Volume 77, Number 72 (Friday, April 13, 2012)]
[Notices]
[Pages 22331-22332]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2012-8930]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Submission for OMB Review; Comment Request; Solar Cell: A Mobile
UV Manager for Smart Phones Phase II (NCI)
Summary: Under the provisions of Section 3507(a)(1)(D) of the
Paperwork Reduction Act of 1995, the National Cancer Institute (NCI),
the National Institutes of Health (NIH), has submitted to the Office of
Management and Budget (OMB) a request to review and approve the
information collection listed below. This proposed information
collection was previously published in the Federal Register on January
27, 2012 (77 FR 4334) and allowed 60-days for public comment. No public
comments were received. The purpose of this notice is to allow an
additional 30 days for public comment. The National Institutes of
Health may not conduct or sponsor, and the respondent is not required
to respond to, an information collection that has been extended,
revised, or implemented on or after October 1, 1995, unless it displays
a currently valid OMB control number.
Proposed Collection: Title: Solar Cell: A Mobile UV Manager for
Smart Phones Phase II (NCI). Type of Information Collection Request:
New. Need and Use of Information Collection: The overall goal of the
study is to design a smart phone application, Solar Cell, which uses
smart phone technology to aid users in protecting their skin from
damaging ultraviolet radiation (UV) in sunlight, a primary cause of
skin cancer. The purpose of this part of the study is to produce,
deploy, and evaluate the effectiveness of a state-of-the-art software
application for smart phones (i.e., mobile application), ``Solar
Cell.'' This software application supports decision-making related to
sun protection and exposure by Americans to reduce the risk of
developing skin cancer attributable to chronic and severe UV exposure
and developing other cancers attributable to vitamin D deficiency. The
Solar Cell mobile smart phone application combines personal and
behavior data with geo-spatial data (i.e., UV Index forecast, time, and
location) and delivers actionable sun protection advice to reduce risk
of skin cancer. Frequency of Response: Once. Affected Public:
Individuals. Type of Respondents: Adults (18 and over) from the U.S.
population who own Android smart phones. The annual reporting burden is
estimated at 308 hours (see Table below). There are no Capital
[[Page 22332]]
Costs, Operating Costs, and/or Maintenance Costs to report.
A.12-1--Estimates of Annual Burden Hours
----------------------------------------------------------------------------------------------------------------
Average time
Type of respondents Instrument Number of Frequency of per response Annual burden
respondents response (min/hour) hours
----------------------------------------------------------------------------------------------------------------
Adults........................ Screener 1,875 1 2/60 63
(Appendix G).
Pre-test 245 1 20/60 82
(Appendix A).
Post-test 245 1 40/60 163
(Appendix B).
---------------------------------------------------------------------------------
Totals.................... ................ .............. .............. .............. 308
----------------------------------------------------------------------------------------------------------------
Request for Comments: Written comments and/or suggestions from the
public and affected agencies should address one or more of the
following points: (1) Evaluate whether the proposed collection of
information is necessary for the proper performance of the function of
the agency, including whether the information will have practical
utility; (2) Evaluate the accuracy of the agency's estimate of the
burden of the proposed collection of information, including the
validity of the methodology and assumptions used; (3) Enhance the
quality, utility, and clarity of the information to be collected; and
(4) Minimize the burden of the collection of information on those who
are to respond, including the use of appropriate automated, electronic,
mechanical, or other technological collection techniques or other forms
of information technology.
Direct Comments to OMB: Written comments and/or suggestions
regarding the item(s) contained in this notice, especially regarding
the estimated public burden and associated response time, should be
directed to the Attention: NIH Desk Officer, Office of Management and
Budget, at OIRA_submission@omb.eop.gov or by fax to 202-395-6974. To
request more information on the proposed project or to obtain a copy of
the data collection plans and instruments, contact Patricia Weber,
DrPH, Program Director, NCI/NIH, SBIR Development Center, 6116
Executive Blvd., Suite 402, Rockville, MD 20852 or call non-toll-free
number 301-594-8106 or email your request, including your address to:
weberpa@mail.nih.gov.
Comments Due Date: Comments regarding this information collection
are best assured of having their full effect if received within 30 days
of the date of this publication.
Dated: April 9, 2012.
Vivian Horovitch-Kelley,
NCI Project Clearance Liaison, National Institutes of Health.
[FR Doc. 2012-8930 Filed 4-12-12; 8:45 am]
BILLING CODE 4140-01-P